AARDVARK THERAPEUTICS INC

Explore why Aardvark Therapeutics (AARD) fell 64.81% today, its current $1.39 price, and how its pipeline and partnerships could spark a rebound.

Aardvark Therapeutics surges after FDA lifts hold on ARD‑101, boosting investor confidence and setting the stage for Phase‑3 trials.

Watch Aardvark Therapeutics (AARD) soar 13% in 24‑hour trading, hitting USD 3.95 amid biotech volatility and near‑SMA resistance.